Abstract:Objective To investigate the clinical efficacy and safety of bronchoscopic interventional freezing combined with 3HRZE/9HR in the treatment of lymph node fistula-type tracheobronchial tuberculosis.Methods Clinical data of 120 patients with lymph node fistula-type tracheobronchial tuberculosis who were diagnosed and treated in our hospital from October 2020 to July 2024 were collected prospectively. They were randomly divided into an observation group (n = 60) and a control group (n = 60). In the control group, patients were treated with 3HRZE/9HR; in the observation group, patients were treated with bronchoscopic interventional freezing combined with 3HRZE/9HR. Compare the clinical efficacy, dyspnea index grading, lung function indexes (FEV1, FVC, and PEF), blood gas analysis (PaO2, SaO2 and PaCO2), and the incidence of adverse reactions before and after the treatment in the observation Group and the control group.Results The total effective rate in the observation group was higher than that in the control group (P < 0.05). After treatment, the grading level of the dyspnea index in the observation group was lower than that in the control group (P < 0.05). After treatment, the levels of FEV1, FVC, and PEF in the observation group were higher than those in the control group, and the differences in FEV1, FVC, and PEF levels before and after treatment in the observation group were greater than those in the control group (P < 0.05). After treatment, the levels of PaO2 and SaO2 in the observation group were higher than those in the control group, while the level of PaCO2 was lower than that in the control group, and the differences in PaO2, SaO2, and PaCO2 levels before and after treatment in the observation group were greater than those in the control group (P < 0.05). There was no statistically significant difference in the total incidence of adverse reactions between the observation group and the control group (P > 0.05).Conclusion Bronchoscopic interventional freezing combined with 3HRZE/9HR in the treatment of lymph node fistula tracheobronchial tuberculosis can effectively improve the therapeutic effect, optimize the patients' clinical indicators and symptoms, and promote the recovery process of the patients, with favorable safety, which is of great value to be promoted and applied in the clinic.